Search
for
Sort by
Research 781–810 of 1000+
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Finasteride is the main inhibitor of 5α-reductase activity in microdissected dermal papillae of human hair follicles
- Reversible decreases of fertility in male Sprague-Dawley rats treated orally with finasteride, a 5α-reductase inhibitor
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson’s disease
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5α-reductase inhibitors
- Androgenetic Alopecia: In Vivo Models
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: Reproductive aspects
- A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma
- Mimosine Dipeptide Enantiomsers: Improved Inhibitors against Melanogenesis and Cyclooxygenase
- Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
- Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- 5α-reductase inhibitors/finasteride
- Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- Analysis of Dermal Papilla Cell Interactome Using STRING Database to Profile the ex Vivo Hair Growth Inhibition Effect of a Vinca Alkaloid Drug, Colchicine
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
- Hypothyroidism in Thyroid Carcinoma Follow-up: Orlistat May Inhibit the Absorption of Thyroxine
- Torilin from<i>Torilis japonica,</i>as a New Inhibitor of Testosterone 5α-Reductase
- Effect of a novel steroid (PM-9) on the inhibition of 5α-reductase present in Penicillium crustosum broths
- Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors